Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 91

1.

Establishing the feasibility of measuring performance in use of addiction pharmacotherapy.

Thomas CP, Garnick DW, Horgan CM, Miller K, Harris AH, Rosen MM.

J Subst Abuse Treat. 2013 Jul;45(1):11-8. doi: 10.1016/j.jsat.2013.01.004. Epub 2013 Mar 13.

PMID:
23490233
[PubMed - indexed for MEDLINE]
Free PMC Article
2.

Pharmacotherapy of dual substance abuse and dependence.

Kenna GA, Nielsen DM, Mello P, Schiesl A, Swift RM.

CNS Drugs. 2007;21(3):213-37. Review.

PMID:
17338593
[PubMed - indexed for MEDLINE]
3.

Developing performance measures for alcohol and other drug services in managed care plans. Washington Circle Group.

McCorry F, Garnick DW, Bartlett J, Cotter F, Chalk M.

Jt Comm J Qual Improv. 2000 Nov;26(11):633-43.

PMID:
11098426
[PubMed - indexed for MEDLINE]
4.

Pharmacotherapy of alcohol use disorders in the Veterans Health Administration.

Harris AH, Kivlahan DR, Bowe T, Humphreys KN.

Psychiatr Serv. 2010 Apr;61(4):392-8. doi: 10.1176/appi.ps.61.4.392.

PMID:
20360279
[PubMed - indexed for MEDLINE]
5.

Pharmacotherapy for alcohol dependence: perceived treatment barriers and action strategies among Veterans Health Administration service providers.

Harris AH, Ellerbe L, Reeder RN, Bowe T, Gordon AJ, Hagedorn H, Oliva E, Lembke A, Kivlahan D, Trafton JA.

Psychol Serv. 2013 Nov;10(4):410-9. doi: 10.1037/a0030949. Epub 2013 Jan 28.

PMID:
23356858
[PubMed - indexed for MEDLINE]
6.

Barriers to use of pharmacotherapy for addiction disorders and how to overcome them.

Oliva EM, Maisel NC, Gordon AJ, Harris AH.

Curr Psychiatry Rep. 2011 Oct;13(5):374-81. doi: 10.1007/s11920-011-0222-2. Review.

PMID:
21773951
[PubMed - indexed for MEDLINE]
7.

Trends in prescription drug abuse and dependence, co-occurrence with other substance use disorders, and treatment utilization: results from two national surveys.

McCabe SE, Cranford JA, West BT.

Addict Behav. 2008 Oct;33(10):1297-305. doi: 10.1016/j.addbeh.2008.06.005. Epub 2008 Jun 12.

PMID:
18632211
[PubMed - indexed for MEDLINE]
Free PMC Article
8.

Advancing performance measures for use of medications in substance abuse treatment.

Thomas CP, Garnick DW, Horgan CM, McCorry F, Gmyrek A, Chalk M, Gastfriend DR, Rinaldo SG, Albright J, Capoccia VA, Harris AH, Harwood HJ, Greenberg P, Mark TL, Un H, Oros M, Stringer M, Thatcher J.

J Subst Abuse Treat. 2011 Jan;40(1):35-43. doi: 10.1016/j.jsat.2010.08.005. Epub 2010 Oct 8.

PMID:
20934836
[PubMed - indexed for MEDLINE]
Free PMC Article
9.

Comparing alternative specifications of quality measures: access to pharmacotherapy for alcohol use disorders.

Fernandes-Taylor S, Harris AH.

J Subst Abuse Treat. 2012 Jan;42(1):102-7. doi: 10.1016/j.jsat.2011.07.005. Epub 2011 Aug 11.

PMID:
21839604
[PubMed - indexed for MEDLINE]
10.

Pharmacologic treatments for drug and alcohol dependence.

Kranzler HR, Amin H, Modesto-Lowe V, Oncken C.

Psychiatr Clin North Am. 1999 Jun;22(2):401-23. Review.

PMID:
10385941
[PubMed - indexed for MEDLINE]
11.

Adapting Washington Circle performance measures for public sector substance abuse treatment systems.

Garnick DW, Lee MT, Horgan CM, Acevedo A; Washington Circle Public Sector Workgroup.

J Subst Abuse Treat. 2009 Apr;36(3):265-77. doi: 10.1016/j.jsat.2008.06.008. Epub 2008 Aug 21.

PMID:
18722075
[PubMed - indexed for MEDLINE]
Free PMC Article
12.

Establishing the feasibility of performance measures for alcohol and other drugs.

Garnick DW, Lee MT, Chalk M, Gastfriend D, Horgan CM, McCorry F, McLellan AT, Merrick EL.

J Subst Abuse Treat. 2002 Dec;23(4):375-85.

PMID:
12495800
[PubMed - indexed for MEDLINE]
13.

Receipt of opioid agonist treatment in the Veterans Health Administration: facility and patient factors.

Oliva EM, Harris AH, Trafton JA, Gordon AJ.

Drug Alcohol Depend. 2012 May 1;122(3):241-6. doi: 10.1016/j.drugalcdep.2011.10.004. Epub 2011 Nov 23.

PMID:
22115887
[PubMed - indexed for MEDLINE]
14.

Care for veterans with mental and substance use disorders: good performance, but room to improve on many measures.

Watkins KE, Pincus HA, Paddock S, Smith B, Woodroffe A, Farmer C, Sorbero ME, Horvitz-Lennon M, Mannle T Jr, Hepner KA, Solomon J, Call C.

Health Aff (Millwood). 2011 Nov;30(11):2194-203. doi: 10.1377/hlthaff.2011.0509. Epub 2011 Oct 19.

PMID:
22012967
[PubMed - indexed for MEDLINE]
15.

Challenges in the adoption of new pharmacotherapeutics for addiction to alcohol and other drugs.

Saxon AJ, McCarty D.

Pharmacol Ther. 2005 Oct;108(1):119-28. Review.

PMID:
16055196
[PubMed - indexed for MEDLINE]
16.

Evidence-based screening, diagnosis, and treatment of substance use disorders among veterans and military service personnel.

Hawkins EJ, Grossbard J, Benbow J, Nacev V, Kivlahan DR.

Mil Med. 2012 Aug;177(8 Suppl):29-38. Review.

PMID:
22953439
[PubMed - indexed for MEDLINE]
17.

Behavioral health issue brief: pharmacotherapy treatment of alcoholism and drug addiction: overview and bibliography: year end report-2002.

Colker AC.

Issue Brief Health Policy Track Serv. 2002 Dec 31:1-6. Review. No abstract available.

PMID:
12875273
[PubMed - indexed for MEDLINE]
18.

Alcohol dependence treatments: comprehensive healthcare costs, utilization outcomes, and pharmacotherapy persistence.

Baser O, Chalk M, Rawson R, Gastfriend DR.

Am J Manag Care. 2011 Jun;17 Suppl 8:S222-34.

PMID:
21761948
[PubMed - indexed for MEDLINE]
19.

Current concepts in pharmacotherapy of substance abuse.

Gottschalk PC, Jacobsen LK, Kosten TR.

Curr Psychiatry Rep. 1999 Dec;1(2):172-8. Review.

PMID:
11122921
[PubMed - indexed for MEDLINE]
20.

Food and Drug Administration approval of buprenorphine-naloxone for office treatment of addiction.

Resnick RB.

Ann Intern Med. 2003 Feb 18;138(4):360. No abstract available.

PMID:
12585846
[PubMed - indexed for MEDLINE]

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk